£3.4M
Oshen Holdings led the Series A round with backing from DSW Ventures, SFC Capital, and Boundary Capital.

4D Medicine develops resorbable biomaterials for 3D printed implants and medical devices.
4D Medicine is a UK-based business that has created a resorbable biomaterial for 3D printed surgical devices and implants. The enterprise operates out of Nottingham with its own development and production facility.
Philip Smith
CEO
Oshen Holdings led the Series A round with backing from DSW Ventures, SFC Capital, and Boundary Capital.